On June 20, 2025, Aytu BioPharma, Inc. amended its Loan and Security Agreement, increasing its term loan to $13 million and extending the maturity date to June 12, 2029. The revolving credit facility was extended along with other financial adjustments, highlighting significant commitments to funding.